In-vivo Contract Research Organization (CRO) Market Size, Share, and Growth Forecast, 2026 – 2033

The global In-vivo contract research organization (CRO) market size is likely to be valued at US$ 5.7 billion in 2026 and is estimated to reach US$ 9.8 billion by 2033, growing at a CAGR of 8.2% during the forecast period 2026 – 2033.

Market growth is driven by rising demand for preclinical testing linked to increasing clinical trial activity and expanding drug development pipelines. Aging populations and higher chronic disease prevalence elevate the need for in vivo studies, especially in oncology, cardiovascular, and metabolic research. Integration of advanced laboratory technologies and animal models improves accuracy, accelerates data generation, and optimizes costs.

Investments in specialized facilities and accredited laboratories ensure regulatory compliance and enable larger studies. Growing clinical adoption of innovative therapies fosters collaboration between pharmaceutical, biotechnology, and contract research organizations. Expansion into emerging markets offers additional opportunities through unmet research needs and cost-efficient operations.